{"disease":{"id":"thrombotic-thrombocytopenic-purpura-acquired","name":"thrombotic thrombocytopenic purpura acquired"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04720261","title":"Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":58,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT05262881","title":"A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Catholic University of the Sacred Heart","has_results":false},{"nct_id":"NCT05135442","title":"Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}